Neuronascent, Inc.   Report issue

For profit Phase 1
Founded: Clarksville MD United States (2004)

Organization Overview

First Clinical Trial
2019
NCT04074837
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Neuronascent, Inc.